96549 ⎘
Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
Sub-classes:LIPID AMINES
#2FARNESOID X RECEPTOR MODULATORS
#3METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID
#4NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#5LIPID COMPOUND AND USE THEREOF
#6Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle
#7OXYSTEROLS AND METHODS OF USE THEREOF
#8COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM
#9COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#10PHARMACEUTICAL COMPOSITION HAVING ANTI-CANCER IMMUNOSTIMULATING EFFECT AND/OR IMMUNE CHECKPOINT INHIBITION POTENTIATING EFFECT
#11Aminosteroids for the Treatment of a PTP1B Associated Disease
#12Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#13IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS
#14Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
#15Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#16ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE
#17Therapeutic DNP derivatives and methods using same
#18COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM
#19Compositions and methods for treating CNS disorders
#20Aminosteroids for the Treatment of a PTP1B Associated Disease
#21Neuroactive steroids, compositions, and uses thereof
#22BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES, INCLUDING INFLAMMATORY BOWEL DISEASE (IBD)
#23OXYSTEROLS AND METHODS OF USE THEREOF
#24Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#25CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#26Therapeutic DNP derivatives and methods using same
#27SMALL MOLECULE MODULATORS OF GUT BACTERIAL BILE ACID METABOLISM
#28Cleavable lipids
#29Small molecules active against gram-negative bacteria
#30CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#31Oxysterols and methods of use thereof
#32Cationic steroidal antimicrobial compounds with endogenous groups
#33STEROL PURIFICATION
#34Fluorinated bile acid derivatives
#35OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS
#36Farnesoid X receptor modulators
#37Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#38Cationic lipids comprising a steroidal moiety
#39Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid
#40Transfection reagents for delivery of nucleic acids
#41NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#42CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#43OXYSTEROLS AND METHODS OF USE THEREOF
#44COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#45Method of synthesis of an ionizable cationic lipid
#46Compositions and methods for making donor-acceptor azetines
#47AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME
#48CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#49LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES
#50Therapeutic DNP derivatives and methods using same
#51Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#52Amphoteric liposomes comprising imino lipids
#53Process for preparation of sulfonyl carbamate bile acid derivatives
#54Combinations Of Lanosterol Or 25-Hydroxycholesterol Including Derivatives Thereof Useful In The Treatment Of Lens Disorders
#55COMPOUNDS FOR TREATING NEAR VISION DISORDERS
#56Aminosteroids for the treatment of a PTP1B associated disease
#57Process for preparation of sulfonylurea bile acid derivatives
#58Cleavable lipids
#59Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#60Therapeutic DNP derivatives and methods using same
#61Certain chemical entities, compositions, and methods
#62Certain chemical entities, compositions, and methods
#63Cleavable lipids
#64Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes
#65STEROIDS AS AGONISTS FOR FXR
#66Compositions for transfecting resistant cell types
#67Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid
#68OXYSTEROL-THERAPEUTIC AGENT DERIVATIVE FOR BONE HEALING
#69Panaxdiol-type ginsenoside derivative, preparation method therefor and use thereof
#70Lanosterol prodrug compound and preparation method therefor and use thereof
#71Certain chemical entities, compositions, and methods
#72Aminosteroids for the treatment of a PTP1B associated disease
#73Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#74Small molecules active against gram-negative bacteria
#75PLANT STEROIDS AND USES THEREOF
#76Cellular signalling inhibitors, their formulations and methods thereof
#77Lipid-based platinum compounds and nanoparticles
#78Neuroactive steroids, compositions, and uses thereof
#79AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#80Chemical compounds and use thereof for improving muscular quality
#81Oxysterol-therapeutic agent derivative for bone healing
#82Process for preparation of sulfonyl carbamate bile acid derivatives
#83Methods and compositions for liposomal formulation of antigens and uses thereof
#84Sialyltransferase inhibitors and uses thereof
#85Bile acid derivatives as FXR agonists and methods of use thereof
#86NATURAL PRODUCT ANALOGS INCLUDING AN ANTI-INFLAMMATORY CYANOENONE PHARMACORE AND METHODS OF USE
#87INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#88Method of synthesis of an ionizable cationic lipid
#89Oxysterols and methods of use thereof
#90Polymerizable polar compound, liquid crystal composition and liquid crystal display device
#91Ionizable cationic lipid for RNA delivery
#92Cleavable lipids
#93Process for preparation of sulfonylurea bile acid derivatives
#94Certain chemical entities, compositions, and methods
#95Treatment of Pulmonary Disease
#96Cleavable Lipids
#97Compositions and methods for treating CNS disorders
#98Steroids as agonists for FXR
#99Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport
#100Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#101Chemical compounds and use thereof for improving muscular quality
#102Amorphous onapristone compositions and methods of making the same
#103Methods and compositions for liposomal formulation of antigens and uses thereof
#104Inhibitors of the farnesoid x receptor and uses in medicine
#105LIPID PARTICLES WITH CATIONIC LIPIDS FOR RNA DELIVERY
#106HYDROPHOBIC CERAGENIN COMPOUNDS AND DEVICES INCORPORATING SAME
#107HYDROPHOBIC CERAGENIN COMPOUNDS AND DEVICES INCORPORATING SAME
#108Ionizable cationic lipid for RNA delivery
#109Farnesoid X receptor modulators
#110Certain chemical entities, compositions, and methods
#111Bone-selective osteogenic oxysterol bisphosphonate analogs
#112Certain chemical entities, compositions, and methods
#113PEGYLATED 7-DEHYDROCHOLESTEROL DERIVATIVES
#114Nanoscale platinum compounds and methods of use thereof
#115Imino compounds for amphoteric liposomes and uses thereof
#116Onium salt, resist composition, and patterning process
#117Methods for the synthesis of ceragenins
#118Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#119General catalyst for C-H functionalization
#120Lipid particles with asymmetric cationic lipids for RNA delivery
#121Therapeutic DNP derivatives and methods using same
#122Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
#123Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
#124Inhibitors of the farnesoid X receptor and uses in medicine
#125Bone-selective osteogenic oxysterol-bone targeting agents
#126Steroids as agonists for FXR
#127Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
#128Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
#129Lipid-based platinum compounds and nanoparticles
#130Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
#131Lipid-based platinum-N-heterocyclic carbene compounds and nanoparticles
#132Compound, active light sensitive or radiation sensitive resin composition, resist film using same, resist-coated mask blank, photomask, pattern forming method, method for manufacturing electronic device, and electronic device
#133Cationic lipids with various head groups for oligonucleotide delivery
#134Cationic steroidal antimicrobial prodrug compositions and uses thereof
#135Certain chemical entities, compositions, and methods
#136Cationic steroidal antimicrobial compounds
#137Asymmetric ionizable cationic lipid for RNA delivery
#138Ionizable cationic lipid for RNA delivery
#139CATIONIC STEROIDAL ANTIMICROBIALS
#140Steroids as Agonists for FXR
#141Ionizable cationic lipid for RNA delivery
#142Plant steroids and uses thereof
#143Hydrophobic ceragenin compounds and devices incorporating same
#144NOVEL OXYSTEROL ANALOGUE, OXY149, INDUCES OSTEOGENESIS AND HEDGEHOG SIGNALING AND INHIBITS ADIPOGENESIS
#145Glycosylation reactions using phenyl(trifluoroethyl)iodonium salts
#146Aminosteroids for the treatment of a PTP1B associated disease
#147Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies
#148NANOPARTICLE PEG MODIFICATION WITH H-PHOSPHONATES
#149Lipopolyamines of spermine type for construction of liposomal transfection systems
#150LIQUID CRYSTAL ALIGNING AGENT
#151Methods for treating inflammation, autoimmune disorders and pain
#152Lipids, lipid compositions, and methods of using them
#153Methods and compositions for liposomal formulation of antigens and uses thereof
#154Cleavable lipids
#155PREPARATION COMPRISING HEXOSE-6-PHOSPHATE-MODIFIED CHOLESTEROL DERIVATIVE
#156INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS COMPRISED IN 5.8 AND 8.5 AND AN ANIONIC COMPOUND BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
#157BILE ACID ANALOG TGR5 AGONISTS
#158Treatment of Pulmonary Disease
#159OSW-1 analogs and conjugates, and uses thereof
#160Steroids as agonists for FXR
#161Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
#162BIOSURFACE ENGINEERING
#163Therapeutic uses for an aminosterol compound
#164Zwitterionic lipids
#165Anti-diabetic compounds
#166Inhibition of bacterial biofilms with aryl carbamates
#167Certain chemical entities, compositions, and methods
#168Ship inhibitors and uses thereof
#169Nanoparticle PEG modification with H-phosphonates
#170Hydrophobic ceragenin compounds and devices incorporating same
#171Hydrogel materials incorporating eluting ceragenin compound
#172BUFADIENOLIDE DERIVATIVES, PREPARING PROCESS THEREOF, COMPOSITION COMPRISING THE SAME AND THE USE THEREOF
#173HYBRID MOLECULES MADE OF LIPIDS AND LIPID-ANALOGOUS COMPOUNDS AND USE THEREOF AS PHARMACEUTICAL OR COSMETIC PREPARATION
#174Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use
#175NOVEL CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR OLIGONUCLEOTIDE DELIVERY
#176Vascular leakage inhibitor
#177AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#178Bile acid or bile salt fatty acid conjugates
#179Certain chemical entities, compositions, and methods
#180Withanolide isolated from and analogs and methods of use thereof
#181Nanoscale platinum compounds and methods of use thereof
#182Cationic lipids with various head groups for oligonucleotide delivery
#183Lipophilic polynucleotide conjugates
#184Betulinic acid derivatives and methods of use thereof
#185Steroids as agonists for FXR
#186Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use
#187BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM
#188Photoactive materials
#189RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS
#190Certain chemical entities, compositions, and methods
#191LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
#192Sterol-Modified Amphiphilic Lipids
#1937-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds
#194Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
#195Method for treating diabetes
#196CATIONIC LIPIDS
#197Photoactive materials
#198Methods and compositions for liposomal formulation of antigens and uses thereof
#199LIPID-BASED NITRIC OXIDE DONORS
#200Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use
#201Steroids as agonists for FXR
#202Conjugates and compositions for cellular delivery
#203CATIONIC LIPIDS
#204Bile acid or bile salt fatty acid conjugates
#205Photoacid generator, resist composition, and patterning process
#206COMPOSITIONS AND METHODS TO PREVENT TOXICITY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS
#207Therapeutic Uses For Aminosterol Compounds
#208STEROL DERIVATIVES, LIPOSOMES COMPRISING STEROL DERIVATIVES AND METHOD OF LOADING LIPOSOMES WITH ACTIVE SUBSTANCES
#209Polycationic sterol derivatives as transfection agents
#210Conjugates of mycophenolic acid
#211Nitrooxyderivative steroidal compounds
#212Steroids as agonists for FXR
#213Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
#214Methods and compositions for mitigating pain
#215Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#216Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
#217Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
#218Photoactive materials
#219Acid-sensitive compounds, their preparation and uses
#220Steroidal compounds
#221Scaffolded maleimide clusters for multivalent peptide assembly
#222Nitrate esters and their use for mitigating cellular damage
#223Acid-sensitive compounds, preparation and use thereof
#224Steroids as agonists for FXR
#225Compound
#226Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
#227Steroid derived antibiotics
#228Conjugates of mycophenolic acid
#229Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds